RESUMEN
Experiments in vivo have established that tooth eruption fails in the absence of parathyroid hormone (PTH)-related protein (PTHrP) action in the microenvironment of the tooth because of the failure of osteoclastic bone resorption on the coronal tooth surface to form an eruption pathway. To elucidate the effects of PTHrP on osteoclast regulation in this environment, we established primary cultures of epithelial stellate reticulum cells and mesenchymal dental follicle (DF) cells surrounding the teeth. When cocultured, these cells are fully capable of supporting the formation of functional osteoclasts in the absence of added splenic osteoclast precursors, osteoblasts, or vitamin D/PTH/PTHrP. Neutralizing the effects of PTHrP resulted in a decrease in the number of osteoclasts formed, suggesting that stellate reticulum-derived PTHrP drives osteoclast formation. DF cells were found to express functional PTH/PTHrP type I receptors, and conditioned media collected from PTHrP-treated DF cells were able to induce bone resorption in the fetal-rat long-bone assay. PTHrP treatment also induced an increase in osteoclast differentiation factor expression and a concomitant decrease in osteoclastogenesis inhibitory factor expression in DF cells. The addition of osteoclastogenesis inhibitory factor resulted in a decrease in the number of osteoclasts formed in the cocultures, suggesting that osteoclast formation is mediated by osteoclast differentiation factor. Thus, PTHrP seems to regulate osteoclast formation via mediation of the DF, in a manner analogous to the osteoblast-mediated process in the peripheral skeleton. The primary coculture system of dental crypt cells also offers a system for the study of osteoclast formation and regulation.
Asunto(s)
Osteoclastos/citología , Osteoclastos/fisiología , Comunicación Paracrina , Proteínas/fisiología , Animales , Comunicación Celular , Diferenciación Celular/fisiología , Células Cultivadas , Técnicas de Cocultivo , Saco Dental/citología , Saco Dental/fisiología , Células Epiteliales/citología , Células Epiteliales/fisiología , Ratones , Ratones Noqueados , Proteína Relacionada con la Hormona ParatiroideaRESUMEN
The parathyroid hormone-related peptide (PTHrP) and PTH/PTHrP receptor genes are widely expressed in the CNS and both are highly expressed in the cerebellar granule cell. We have shown previously that PTHrP gene expression in granule cells is depolarization-dependent in vitro and is regulated specifically by Ca2+ influx via L-type voltage-sensitive calcium channels (L-VSCCs). Kainic acid induces long-latency excitotoxicity in granule cells via L-VSCC-mediated Ca2+ influx. Here, we show that PTHrP is just as effective as the L-VSCC blocker, nitrendipine (NTR), in preventing kainate excitotoxicity. A competitive inhibitor of PTHrP binding abrogates its neuroprotective effect. Both NTR and PTHrP decrease 45Ca2+ influx to the same degree. These findings suggest that PTHrP functions in an autocrine/paracrine neuroprotective feedback loop that can combat L-VSCC-mediated excitotoxcity.
Asunto(s)
Canales de Calcio Tipo L/efectos de los fármacos , Calcio/metabolismo , Cerebelo/efectos de los fármacos , Ácido Kaínico/toxicidad , Fármacos Neuroprotectores/farmacología , Proteínas/farmacología , Animales , Apoptosis , Bloqueadores de los Canales de Calcio/farmacología , Canales de Calcio Tipo L/metabolismo , Células Cultivadas , Cerebelo/citología , Cerebelo/metabolismo , Agonistas de Aminoácidos Excitadores/toxicidad , Potenciales de la Membrana/efectos de los fármacos , Neuronas/citología , Neuronas/efectos de los fármacos , Neuronas/metabolismo , Fármacos Neuroprotectores/metabolismo , Nitrendipino/farmacología , Hormona Paratiroidea/metabolismo , Hormona Paratiroidea/farmacología , Proteína Relacionada con la Hormona Paratiroidea , Fragmentos de Péptidos/farmacología , Proteínas/metabolismo , RatasRESUMEN
PTH-related protein (PTHrP) is a normal product of many excitable cells of the nervous and endocrine systems. Functions of PTHrP in these tissues are, however, currently unknown. Prior study has suggested that a relationship exists between PTHrP and the L-type voltage-sensitive Ca2+ channel (L-VSCC). For example, in cerebellar granule neurons PTHrP gene transcription is regulated by Ca2+ influx specifically through this channel. Amino-terminal PTHrP products signal via the widely expressed PTH/PTHrP receptor, which is linked to both protein kinase A and C. These second messengers are known modulators of L-VSCC conductance. To determine whether PTHrP can modulate L-VSCC function, we studied catecholamine secretion in a PC 12 clone expressing the PTH/PTHrP receptor but not PTHrP. We found that PTHrP(1-36) (100 nM) to be an ineffective secretagogue for resting cells, but its presence markedly potentiates secretion to K+ depolarization. The PTHrP-augmented catecholamine secretion depends entirely upon L-VSCC Ca2+ influx and rapidly inactivates. Similar effects were produced by (Bu)2cAMP but not by carbachol. These observations support the hypothesis that PTHrP can regulate L-VSCC conductance. In the normal adrenal medulla that expresses both PTHrP and its receptor, PTHrP may act in an autocrine/paracrine fashion to modify catecholamine secretion.
Asunto(s)
Canales de Calcio/fisiología , Dopamina/metabolismo , Células PC12/efectos de los fármacos , Células PC12/metabolismo , Proteínas/farmacología , Animales , Bucladesina/farmacología , Sinergismo Farmacológico , Conductividad Eléctrica , Electrofisiología , Proteína Relacionada con la Hormona Paratiroidea , RatasRESUMEN
Emerging evidence suggests that parathyroid hormone-related peptide (PTHrP) serves as a regulator of the development and/or differentiation of a number of organs, including endochondral bone, the tooth, and the mammary gland. Although disruption of the PTHrP gene by homologous recombination results in a lethal chondrodystrophy, PTHrP-knockout mice that have been rescued by the transgenic replacement of the peptide in cartilage display abnormalities in ectodermally derived structures including the skin. At 6-8 wk of age, these rescued PTHrP-knockout mice displayed a markedly thinned epidermis and striking hyperkeratosis, hypoplastic sebaceous glands, and a fibrotic dermis. In contrast, transgenic mice that overexpress PTHrP by virtue of the human keratin-14 promoter displayed a thickened ventral epidermis with marked acanthosis and papillomatosis, hyperplastic sebaceous glands, and a cellular dermis. The absence of PTHrP appeared to result in the reduction of the basal keratinocyte compartment and premature acquisition of suprabasal and granular differentiation markers, whereas overexpression of the peptide generated reciprocal findings. No difference in the epidermal proliferation rate was found in PTHrP-null skin and although an increase was observed in keratin 14-PTHrP transgenic animals, their epidermis did not express the hyperplasia marker K6. Finally, the replacement of PTHrP in the basal keratinocytes of rescued PTHrP-knockout mice under the direction of the keratin 14 promoter reversed the abnormalities seen in PTHrP-null skin. These findings suggest that PTHrP regulates the rate of keratinocyte differentiation in the skin of adult mice.
Asunto(s)
Proteínas/fisiología , Piel/citología , Envejecimiento/genética , Animales , Diferenciación Celular/genética , Regulación de la Expresión Génica , Ratones , Ratones Noqueados , Ratones Transgénicos , Hormona Paratiroidea/genética , Hormona Paratiroidea/fisiología , Proteína Relacionada con la Hormona Paratiroidea , Proteínas/genética , Anomalías Cutáneas/genética , Anomalías Cutáneas/patologíaRESUMEN
Parathyroid hormone-related protein (PTHrP) was originally discovered as a tumor product that causes humoral hypercalcemia of malignancy. PTHrP is now known to be widely expressed in normal tissues and growing evidence suggests that it is an important developmental regulatory molecule. We had previously reported that overexpression of PTHrP in the mammary glands of transgenic mice impaired branching morphogenesis during sexual maturity and early pregnancy. We now demonstrate that PTHrP plays a critical role in the epithelial-mesenchymal communications that guide the initial round of branching morphogenesis that occurs during the embryonic development of the mammary gland. We have rescued the PTHrP-knockout mice from neonatal death by transgenic expression of PTHrP targeted to chondrocytes. These rescued mice are devoid of mammary epithelial ducts. We show that disruption of the PTHrP gene leads to a failure of the initial round of branching growth that is responsible for transforming the mammary bud into the rudimentary mammary duct system. In the absence of PTHrP, the mammary epithelial cells degenerate and disappear. The ability of PTHrP to support embryonic mammary development is a function of amino-terminal PTHrP, acting via the PTH/PTHrP receptor, for ablation of the PTH/PTHrP receptor gene recapitulates the phenotype of PTHrP gene ablation. We have localized PTHrP expression to the embryonic mammary epithelial cells and PTH/PTHrP receptor expression to the mammary mesenchyme using in situ hybridization histochemistry. Finally, we have rescued mammary gland development in PTHrP-null animals by transgenic expression of PTHrP in embryonic mammary epithelial cells. We conclude that PTHrP is a critical epithelial signal received by the mammary mesenchyme and involved in supporting the initiation of branching morphogenesis.
Asunto(s)
Regulación del Desarrollo de la Expresión Génica/genética , Glándulas Mamarias Animales/crecimiento & desarrollo , Proteínas/genética , Animales , Células Cultivadas , Eliminación de Gen , Técnicas de Transferencia de Gen , Inmunohistoquímica , Hibridación in Situ , Glándulas Mamarias Animales/embriología , Glándulas Mamarias Animales/patología , Ratones , Ratones Noqueados , Morfogénesis/fisiología , Proteína Relacionada con la Hormona Paratiroidea , Fenotipo , Proteínas/fisiología , ARN Mensajero/análisis , Receptores de Hormona Paratiroidea/genética , Receptores de Hormona Paratiroidea/fisiologíaRESUMEN
Parathyroid hormone-related peptide (PTHrP) appears to play a major role in skeletal development. Targeted disruption of the PTHrP gene in mice causes skeletal dysplasia with accelerated chondrocyte maturation (Amizuka, N., H. Warshawsky, J.E. Henderson, D. Goltzman, and A.C. Karaplis. 1994. J. Cell Biol. 126:1611-1623; Karaplis, A.C., A. Luz, J. Glowacki, R.T. Bronson, V.L.J. Tybulewicz, H.M. Kronenberg, and R.C. Mulligan. 1994. Genes Dev. 8: 277-289). A constitutively active mutant PTH/PTHrP receptor has been found in Jansen-type human metaphyseal chondrodysplasia, a disease characterized by delayed skeletal maturation (Schipani, E., K. Kruse, and H. Jüppner. 1995. Science (Wash. DC). 268:98-100). The molecular mechanisms by which PTHrP affects this developmental program remain, however, poorly understood. We report here that PTHrP increases the expression of Bcl-2, a protein that controls programmed cell death in several cell types, in growth plate chondrocytes both in vitro and in vivo, leading to delays in their maturation towards hypertrophy and apoptotic cell death. Consequently, overexpression of PTHrP under the control of the collagen II promoter in transgenic mice resulted in marked delays in skeletal development. As anticipated from these results, deletion of the gene encoding Bcl-2 leads to accelerated maturation of chondrocytes and shortening of long bones. Thus, Bcl-2 lies downstream of PTHrP in a pathway that controls chondrocyte maturation and skeletal development.
Asunto(s)
Cartílago/crecimiento & desarrollo , Proteínas/fisiología , Proteínas Proto-Oncogénicas c-bcl-2/fisiología , Transducción de Señal/fisiología , Animales , Apoptosis , Desarrollo Óseo , Cartílago/química , Cartílago/patología , Células Cultivadas , Colágeno/genética , Expresión Génica , Placa de Crecimiento/química , Placa de Crecimiento/patología , Humanos , Hipertrofia , Ratones , Ratones Noqueados , Ratones Transgénicos , Especificidad de Órganos , Proteína Relacionada con la Hormona Paratiroidea , Regiones Promotoras Genéticas/genética , Proteínas/genética , Proteínas/farmacología , Proteínas Proto-Oncogénicas/análisis , Proteínas Proto-Oncogénicas c-bcl-2/análisis , Proteínas Proto-Oncogénicas c-bcl-2/genética , Proteínas Recombinantes de Fusión , Proteína X Asociada a bcl-2RESUMEN
Parathyroid hormone-related protein (PTHrP) was originally discovered because of its role in humoral hypercalcemia of malignancy (HHM), a common metabolic complication of many types of cancer. In HHM, PTHrP is released into the circulation by malignant cells and cross reacts with parathyroid hormone (PTH) receptors in bone and kidney, which results in hypercalcemia. In recent years, it has become clear that PTHrP is a normal product of many adult and fetal tissues where it appears to act in an autocrine and/or paracrine fashion to regulate organogenesis. This article explores the molecular evolution of PTHrP and how this understanding has begun to shed some light on the molecular mechanisms responsible for the biochemical manifestations of HHM. In addition, the normal biological function of PTHrP is discussed, with an emphasis on its role as a developmental regulatory molecule.
Asunto(s)
Hipercalcemia/metabolismo , Proteínas de Neoplasias/metabolismo , Proteínas/fisiología , Animales , Huesos/citología , Huesos/metabolismo , Mama/citología , Mama/crecimiento & desarrollo , Humanos , Ratones , Microscopía , Hormona Paratiroidea/metabolismo , Proteína Relacionada con la Hormona ParatiroideaRESUMEN
Parathyroid hormone (PTH)-related peptide (PTHrP) is expressed in the adult mammalian brain, but its function is unknown. Here we show that PTHrP and the PTH/PTHrP receptor are products of cerebellar granule cells in primary culture. Granule cells maintained under depolarizing conditions (25 mM K+) make and release PTHrP. Further, PTHrP-(1-36) stimulates cAMP accumulation in granule neurons in a dose-dependent manner with half-maximal activation at approximately 16 nM. Granule cell PTHrP mRNA is activity-dependent, and the pathway of regulation depends absolutely on the flux of Ca2+ ions through the L-type voltage-sensitive Ca2+ channel and the Ca2+/calmodulin kinase cascade. PTHrP is therefore a neuropeptide whose regulation depends upon L-type voltage-sensitive Ca2+ channel activity, and the gene is expressed under conditions that promote granule cell survival.
Asunto(s)
Canales de Calcio/metabolismo , Proteínas Quinasas Dependientes de Calcio-Calmodulina/metabolismo , Cerebelo/metabolismo , Biosíntesis de Proteínas , Proteínas Quinasas/metabolismo , Animales , Calcio/metabolismo , Células Cultivadas , Cerebelo/citología , Femenino , Proteína Relacionada con la Hormona Paratiroidea , Potasio/metabolismo , ARN Mensajero/metabolismo , Ratas , Ratas Sprague-Dawley , Receptor de Hormona Paratiroídea Tipo 1 , Receptores de Hormona Paratiroidea/metabolismo , Veratridina/farmacologíaRESUMEN
Parathyroid hormone-related peptide (PTHrP) was initially identified as a product of malignant tumors that mediates paraneoplastic hypercalcemia. It is now known that the parathyroid hormone (PTH) and PTHrP genes are evolutionarily related and that the products of these two genes share a common receptor, the PTH/PTHrP receptor. PTHrP and the PTH/PTHrP receptor are widely expressed in both adult and fetal tissues, and recent gene-targeting and disruption experiments have implicated PTHrP as a developmental regulatory molecule. Apparent PTHrP functions include the regulation of endochondral bone development, of hair follicle formation, and of branching morphogenesis in the breast. Herein, we report that overexpression of PTHrP in chondrocytes using the mouse type II collagen promoter induces a novel form of chondrodysplasia characterized by short-limbed dwarfism and a delay in endochondral ossification. This features a delay in chondrocyte differentiation and in bone collar formation and is sufficiently marked that the mice are born with a cartilaginous endochondral skeleton. In addition to the delay, chondrocytes in the transgenic mice initially become hypertrophic at the periphery of the developing long bones rather than in the middle, leading to a seeming reversal in the pattern of chondrocyte differentiation and ossification. By 7 weeks, the delays in chondrocyte differentiation and ossification have largely corrected, leaving foreshortened and misshapen but histologically near-normal bones. These findings confirm a role for PTHrP as an inhibitor of the program of chondrocyte differentiation. PTHrP may function in this regard to maintain the stepwise differentiation of chondrocytes that initiates endochondral ossification in the midsection of endochondral bones early in development and that also permits linear growth at the growth plate later in development.
Asunto(s)
Desarrollo Óseo/genética , Placa de Crecimiento/crecimiento & desarrollo , Osteocondrodisplasias/genética , Biosíntesis de Proteínas , Proteínas/genética , Animales , Enanismo/genética , Regulación del Desarrollo de la Expresión Génica , Placa de Crecimiento/metabolismo , Humanos , Ratones , Ratones Endogámicos C57BL , Ratones Endogámicos , Ratones Transgénicos , Osteocondrodisplasias/fisiopatología , Hormona Paratiroidea/genética , Proteína Relacionada con la Hormona Paratiroidea , Reacción en Cadena de la Polimerasa , Procolágeno/biosíntesis , Procolágeno/genética , Regiones Promotoras Genéticas , Secuencias Reguladoras de Ácidos Nucleicos , Transcripción GenéticaRESUMEN
Parathyroid hormone-related protein (PTHrP) is a normal secretory product of a variety of squamous epithelia, including epidermal keratinocytes. Only a subset of squamous carcinomas, however, express the gene at levels sufficient to cause humoral hypercalcemia. In the present study, comparison of PTHrP expression levels with p53 functional status in a series of squamous carcinoma lines has revealed an association between expression of specific mutant isoforms of p53 and very low levels of PTHrP mRNA. Evaluation of p53 isoforms with mutations in codons 248 and 273 showed them to be capable of repressing PTHrP gene expression in a high-expressing, p53-negative squamous line by approximately 50%. Conversely, inactivation of an endogenous mutant p53 with E1B proteins resulted in an increase in PTHrP expression in a low-expressing cell line. Subsequent analysis of promoter-specific PTHrP transcripts in a p53-negative squamous line transfected with mutant p53 isoforms suggested that down-regulation occurred primarily at the two TATA-based promoters. Direct testing of a murine PTHrP reporter construct in transient transfection assays confirmed the capacity of the 248 and 273 mutants to repress this TATA-based promoter, although only about half as effectively as wild-type p53.
Asunto(s)
Carcinoma de Células Escamosas/metabolismo , Mutación , Biosíntesis de Proteínas , Proteína p53 Supresora de Tumor/fisiología , Proteínas E1B de Adenovirus/biosíntesis , Proteínas E1B de Adenovirus/genética , Carcinoma de Células Escamosas/genética , Carcinoma de Células Escamosas/patología , Expresión Génica , Genes Reporteros , Genes p53 , Humanos , Isomerismo , Queratinocitos/metabolismo , Queratinocitos/fisiología , Proteína Relacionada con la Hormona Paratiroidea , Regiones Promotoras Genéticas , Proteínas/genética , ARN Mensajero/genética , ARN Mensajero/metabolismo , TATA Box , Transfección , Células Tumorales Cultivadas , Proteína p53 Supresora de Tumor/genéticaRESUMEN
Humoral hypercalcemia of malignancy (HHM) is caused by the secretion of parathyroid hormone-related protein (PTHrP) by tumor cells, and tumors of squamous histology are the ones most commonly complicated by HHM. To determine why some squamous tumors cause HHM and others do not, we quantitated the levels of PTHrP mRNA expression and PTHrP secretion in a series of eight squamous tumor lines. As anticipated, we found that the level of PTHrP mRNA expression in individual lines correlated with their PTHrP secretion rates. However, PTHrP mRNA levels varied widely in individual lines, and only those tumor lines with the highest levels of PTHrP gene expression were able to cause hypercalcemia in athymic mice. We found that a specific segment of the PTHrP promoter could reproduce the relative pattern of PTHrP gene expression when cloned in front of a chloramphenicol acetyltransferase reporter gene and transiently transfected into these squamous lines. Deletional analysis confirmed that specific sequences within the PTHrP gene promoter appeared to be involved in the transactivation of the gene in tumor lines expressing high levels of PTHrP mRNA. These data suggest that the ability of a given squamous tumor to cause HHM is ultimately a function of its level of PTHrP gene expression, which in turn appears to be a function of the ability of specific transcription factors to transactivate PTHrP gene expression.
Asunto(s)
Carcinoma de Células Escamosas/metabolismo , Hipercalcemia/metabolismo , Neoplasias Experimentales/metabolismo , Proteínas/genética , Animales , Carcinoma de Células Escamosas/complicaciones , Carcinoma de Células Escamosas/genética , Regulación Neoplásica de la Expresión Génica , Hipercalcemia/etiología , Hipercalcemia/genética , Ratones , Ratones Desnudos , Trasplante de Neoplasias , Neoplasias Experimentales/complicaciones , Neoplasias Experimentales/genética , Proteína Relacionada con la Hormona Paratiroidea , Biosíntesis de Proteínas , Activación Transcripcional , Células Tumorales CultivadasRESUMEN
Parathyroid hormone-related protein (PTHrP) was discovered as a result of a search for the circulating factor secreted by cancers which causes the common paraneoplastic syndrome humoral hypercalcemia of malignancy. Since the identification of the peptide in 1982 and the cloning of the cDNA in 1987, it has become clear that PTHrP is a prohormone that is posttranslationally cleaved by prohormone convertases to yield a complex family of peptides, each of which is believed to have its own receptor. It is also clear that the PTHrP gene is expressed not only in cancers but also in the vast majority of normal tissues during adult and/or fetal life. In contrast to the situation in humoral hypercalcemia of malignancy in which PTHrP plays the role of a classical "endocrine" hormone, under normal circumstances PTHrP plays predominantly paracrine and/or autocrine roles. These apparent physiological functions are also complex and appear to include 1) regulation of smooth muscle (vascular, intestinal, uterine, bladder) tone, 2) regulation of transepithelial (renal, placental, oviduct, mammary gland) calcium transport, and 3) regulation of tissue and organ development, differentiation, and proliferation. In this review, the discovery of PTHrP, the structure of its gene and its cDNAs, and the posttranslational processing of the initial translation products are briefly reviewed. Attention is then focused on a detailed organ system-oriented review of the normal physiological functions of PTHrP.
Asunto(s)
Hormona Paratiroidea/fisiología , Proteínas/fisiología , Secuencia de Aminoácidos , Animales , Genes , Humanos , Datos de Secuencia Molecular , Proteína Relacionada con la Hormona Paratiroidea , Biosíntesis de Proteínas , Procesamiento Proteico-Postraduccional , Proteínas/genética , Receptores de Hormona Paratiroidea/metabolismo , Valores de Referencia , Transducción de SeñalRESUMEN
Parathyroid hormone-related protein (PTHrP) was originally discovered as the tumor product that causes humoral hypercalcemia of malignancy. PTHrP is now known to be widely expressed in many normal fetal tissues where it may participate in the regulation of organogenesis. In this report, we document that overexpression of PTHrP in myoepithelial cells in the mammary glands of transgenic mice resulted in a form of breast hypoplasia characterized by a profound defect in branching morphogenesis of the developing mammary duct system. In addition, transgenic mice manifested a defect in lobuloalveolar development during pregnancy that seemed to be, in part, the consequence of an impaired ability to form terminal ducts in response to estrogen and progesterone stimulation. The effects of PTHrP on branching morphogenesis during breast development appeared to be the result of amino-terminal PTH-like sequences that signal through the PTH/PTHrP receptor, since overexpression of parathyroid hormone itself in the mammary glands of transgenic mice caused a similar development phenotype, and delivery of PTHrP (1-36) via locally implanted slow-release pellets impaired breast development in normal mice. These results suggest that PTHrP, which is a native product of mammary epithelial and myoepithelial cells may participate in normal breast development, perhaps as a locally secreted growth inhibitor.
Asunto(s)
Glándulas Mamarias Animales/embriología , Mesodermo/fisiología , Hormona Paratiroidea/genética , Proteínas/genética , Transducción de Señal/genética , Animales , Secuencia de Bases , Técnicas de Cultivo de Célula , Implantes de Medicamentos , Epitelio/embriología , Femenino , Expresión Génica , Inmunohistoquímica , Glándulas Mamarias Animales/citología , Glándulas Mamarias Animales/efectos de los fármacos , Ratones , Ratones Transgénicos , Datos de Secuencia Molecular , Morfogénesis/genética , Hormona Paratiroidea/metabolismo , Proteína Relacionada con la Hormona Paratiroidea , Reacción en Cadena de la Polimerasa , Proteínas/metabolismo , Receptores de Hormona Paratiroidea/metabolismoRESUMEN
Parathyroid hormone-related protein (PTHrP) is endoproteolytically processed to yield a family of mature secretory forms. These include an amino-terminal, a mid-region, and a carboxyl-terminal form. Prior studies suggested that the mid-region form is secreted via the regulated secretory pathway, whereas the amino- and carboxyl-terminal forms are secreted via the constitutive pathway. Further, PTHrP is unusual in that it is produced under normal circumstances by neuroendocrine cell types as well as by prototypical constitutively secreting cell types. The potential for cell-specific secretory pathway use by PTHrP has not been explored. Using immunohistochemical and perifusion techniques, we demonstrate that all three PTHrP daughter peptides are secreted via the regulated pathway in neuroendocrine cells. In contrast, all three daughter peptides are secreted in a constitutive fashion by non-neuroendocrine cells. Thus, the secretion of PTHrP is unique in that it appears to be cell-specific. When it is expressed in neuroendocrine cells that contain the regulated pathway, it is secreted in a regulated fashion; when it is expressed in non-neuroendocrine cells, it defaults to the constitutive pathway. This phenomenon has not previously been described for a polypeptide hormone in naturally occurring cells.
Asunto(s)
Proteínas/metabolismo , Animales , Carcinoma de Células Escamosas/metabolismo , Fibroblastos/metabolismo , Proteína Relacionada con la Hormona Paratiroidea , Ratas , Células Tumorales CultivadasRESUMEN
The relative importance of dietary factors in causing hypercalciuria was assessed in 282 unselected patients with calcium oxalate kidney stones. The 124 patients found to be hypercalciuric on either their customary free diet or on a 25-mmol (1000-mg) calcium defined diet (or both), were classified according to their pattern of calcium excretion on the two diets. Unexpectedly, about half of the patients who were hypercalciuric on their free diet exhibited a calcium excretion that fell markedly or normalized on the high-calcium defined diet. These patients were defined as having dietary hypercalciuria. For all 282 patients, multiple-regression analysis suggested that dietary sodium was at least as important as was dietary calcium, and more important than dietary protein, carbohydrate, phosphorus, purine, or oxalate, in contributing to calcium excretion on the free diet. Among the 124 hypercalciuric patients, urinary calcium excretion increased by 0.0193 mmol (0.77 mg) per mmol sodium excretion. Dietary habits, particularly a high sodium intake, may commonly contribute to hypercalciuria in patients with calcium oxalate stones.
Asunto(s)
Oxalato de Calcio/análisis , Calcio de la Dieta/metabolismo , Calcio/orina , Cálculos Renales/química , Sodio en la Dieta/metabolismo , Adolescente , Adulto , Anciano , Calcio de la Dieta/efectos adversos , Creatinina/orina , Estudios Transversales , Femenino , Estudios de Seguimiento , Humanos , Cálculos Renales/etiología , Masculino , Persona de Mediana Edad , Análisis de Regresión , Estudios Retrospectivos , Sodio en la Dieta/efectos adversos , Sodio en la Dieta/orina , Espectrofotometría AtómicaRESUMEN
Parathyroid hormone-related protein (PTHrP) is expressed by malignant tumors and leads to the syndrome of humoral hypercalcemia of malignancy. It is also expressed by a wide variety of nonmalignant tissues, in which it appears to play distinct paracrine and/or autocrine roles. The human PTHrP gene encodes three cDNA-predicted initial translational products of 139, 141, and 173 amino acids. Most human cell lines contain mRNAs encoding all three PTHrP isoforms. The physiological rationale for the existence of these three highly similar transcripts is unknown. In order to determine whether the protein products derived from these three transcripts differ, we transfected Chinese hamster ovary (CHO) cells and rat insulinoma (RIN) cells individually with cDNAs encoding human PTHrP(1-139), PTHrP(1-141), and PTHrP(1-173). Cell extracts and conditioned medium were then chromatographed using reversed-phase HPLC and analyzed using region-specific PTHrP immunoassays. As we had previously observed in SKRC-1 (renal cell carcinoma) and RIN(1-141) cells, multiple amino-terminal PTHrP species as well as a separate midregion PTHrP species were identified in all six cell lines. In addition, both CHO and RIN cell lines transfected with the PTHrP(1-139) construct contained a previously unrecognized carboxy-terminal fragment that reacted with a PTHrP(109-138) antiserum. This carboxy-terminal fragment was physically distinct from the midregion fragment discovered earlier and was also present in conditioned medium, indicating that it is a secretory form, rather than a biosynthetic intermediate or a degradation product.(ABSTRACT TRUNCATED AT 250 WORDS)
Asunto(s)
Hormona Paratiroidea/metabolismo , Procesamiento Proteico-Postraduccional , Proteínas/metabolismo , Secuencia de Aminoácidos , Animales , Células CHO , Cromatografía de Afinidad , Cromatografía Líquida de Alta Presión , Cricetinae , Cricetulus , Medios de Cultivo Condicionados , Humanos , Inmunohistoquímica , Datos de Secuencia Molecular , Hormona Paratiroidea/química , Proteína Relacionada con la Hormona Paratiroidea , Fragmentos de Péptidos/metabolismo , Proteínas/química , Células Tumorales CultivadasRESUMEN
The parathyroid hormone-related peptide (PTHrP) gene has been reported to be subject to a wide variety of physiological and pharmacological controls. Two distinct patterns of PTHrP mRNA response have been recognized, one characterized by a prolonged or plateau response lasting many hours to days and the second characterized by rapid induction-deinduction kinetics and lasting 1 to several hours. The kinetics of the second pattern are similar to those displayed by primary response genes like nuclear protooncogenes, cytokines, and growth factors. In GH4C1 rat pituitary cells, 17 beta-estradiol induced a rapid and transient increase in PTHrP mRNA expression, with a peak response at 1-2 h. This response appeared to be due to a rapid and transient burst in gene transcription, which by runoff analysis was maximal at 20-40 min and declined thereafter. PTHrP mRNA half-life was 30 min in these cells and was unaltered by estradiol. Cycloheximide did not block the 17 beta-estradiol-induced response but rather prolonged it, and runoff analysis revealed that this effect was due to a prolongation or persistence of PTHrP gene transcription. These findings suggest that the transient nature of the native response reflects the effects of an estrogen-inducible repressor. All of these features are characteristic of a prototypical primary response gene.
Asunto(s)
Estradiol/farmacología , Regulación de la Expresión Génica/efectos de los fármacos , Proteínas/genética , Animales , Línea Celular , Cicloheximida/farmacología , Diclororribofuranosil Benzoimidazol/farmacología , Cinética , Proteína Relacionada con la Hormona Paratiroidea , ARN Mensajero/metabolismo , Ratas , Transcripción Genética/efectos de los fármacosRESUMEN
Parathyroid hormone-related peptide (PTHrP) was initially discovered as the cause of the syndrome of humoral hypercalcemia of malignancy. Subsequently, the PTHrP gene has been shown to be expressed in a wide variety of normal tissues, including skin. Because the biological function of PTHrP in skin remains unknown, we used the human keratin 14 promoter to target overexpression of PTHrP to the skin of transgenic mice. We achieved a 10-fold level of overexpression in skin, and human keratin 14 promoter-PTHrP transgenic mice displayed a disturbance in normal hair follicle development. These mice either failed to initiate follicle development or showed a delay in the initiation of follicles. These findings suggest that PTHrP normally plays a role in the early stages of hair follicle development and support previous speculation that the peptide may function in regulating cellular differentiation.
Asunto(s)
Cabello/crecimiento & desarrollo , Hormona Paratiroidea/metabolismo , Proteínas/metabolismo , Piel/metabolismo , Animales , Femenino , Expresión Génica , Cabello/patología , Humanos , Queratinas/genética , Ratones , Ratones Transgénicos , Hormona Paratiroidea/genética , Hormona Paratiroidea/fisiología , Proteína Relacionada con la Hormona Paratiroidea , Fenotipo , Regiones Promotoras Genéticas , Proteínas/genética , Proteínas/fisiología , Piel/patologíaRESUMEN
Hypercalcemia is the most common metabolic complication of cancer. Malignancy-associated hypercalcemia (MAHC) can be divided into two syndromes, humoral hypercalcemia of malignancy (HHM) and local osteolytic hypercalcemia (LOH), based on whether a circulating hormone or local paracrine factors mediate accelerated bone resorption. Over the past decade, studies have shown that parathyroid hormone-related protein is the cause of the HHM syndrome, and recent data suggest that this protein may also play a paracrine role in some patients with local osteolytic hypercalcemia. Study of the regulation of parathyroid hormone-related protein gene expression is beginning to shed some light on the molecular mechanisms responsible for this common clinical problem.
Asunto(s)
Hipercalcemia/etiología , Hipercalcemia/fisiopatología , Proteínas de Neoplasias/fisiología , Neoplasias/complicaciones , Hormona Paratiroidea/fisiología , Proteínas/fisiología , Resorción Ósea/etiología , Resorción Ósea/fisiopatología , Regulación Neoplásica de la Expresión Génica , Humanos , Proteínas de Neoplasias/genética , Neoplasias/genética , Neoplasias/fisiopatología , Osteólisis/etiología , Osteólisis/fisiopatología , Síndromes Paraneoplásicos/etiología , Síndromes Paraneoplásicos/fisiopatología , Hormona Paratiroidea/genética , Proteína Relacionada con la Hormona Paratiroidea , Proteínas/genéticaRESUMEN
Tumor production of a parathyroid hormone-related peptide (PTHrP) is a common cause of the syndrome of humoral hypercalcemia of malignancy, which is frequently associated with renal cell carcinomas. Why certain renal cell carcinomas produce PTHrP while others do not is unknown. Using a system of 12 human renal carcinoma cell lines which either do (n = 6) or do not (n = 6) produce PTHrP, we found that the expression of the PTHrP gene in these cell lines is controlled at the transcriptional level. Transfection studies failed to demonstrate variation in PTHrP promoter activity in these cell lines sufficient to account for the differential PTHrP expression, implicating a cis-acting mechanism. Transcription of the PTHrP gene in these cell lines was found to correlate with the methylation state of specific CpG dinucleotides located within the promoter region but outside a CpG island. The functional importance of this mechanism of control was confirmed by the ability of the demethylating agent, 5-azacytidine, to induce PTHrP mRNA expression in previously nonexpressing cell lines.